Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11343549 | 0.98 | ALDH1A1 (0.38) | ALDH1A1TDP1TP53GAAMEN1 | |
| SCHEMBL7736962 | 0.84 | TRPA1 (0.37) | ALDH1A1TDP1TP53GAAMEN1 | |
| SCHEMBL7170552 | 0.82 | TDP1 (0.44) | ALDH1A1TDP1TP53GAAMEN1 | |
| SCHEMBL17423674 | 0.80 | ACHE (0.42) | ALDH1A1GAAHSD17B10CYP1A2TSHR | |
| SCHEMBL10605055 | 0.80 | RXRB (0.30) | — | |
| SCHEMBL11330503 | 0.80 | TDP1 (0.43) | ALDH1A1TDP1TP53GAAMEN1 | |
| SCHEMBL11026947 | 0.78 | CASP1 (0.48) | ALDH1A1TDP1GAAMEN1KMT2A | |
| SCHEMBL3924020 | 0.78 | HDAC4 (0.35) | ALDH1A1MEN1KMT2AHPGDNPC1 | |
| SCHEMBL5175336 | 0.78 | MAOB (0.35) | ALDH1A1TDP1TP53GAAMEN1 | |
| SCHEMBL10707086 | 0.78 | RAB9A (0.37) | ALDH1A1GAAMEN1KMT2ATRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9536633-B2 | Metallic composite and composition thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-01-03 | — | — | US | disclosed |
| US-9412487-B2 | Silver-(conjugated compound) composite | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-08-09 | — | — | US | disclosed |
| US-20120168693-A1 | SILVER-(CONJUGATED COMPOUND) COMPOSITE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-07-05 | — | — | US | disclosed |
| US-20120032121-A1 | METALLIC COMPOSITE AND COMPOSITION THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-09 | — | — | US | disclosed |
| WO-1996009173-A1 | NOVEL COLORANT FOR USE IN BUSINESS RECORDING | INDIANA UNIVERSITY FOUNDATION (US) | 1996-03-28 | — | — | WO | disclosed |
| US-5453522-A | Colorant for use in business recording | INDIANA UNIVERSITY FOUNDATION (US) | 1995-09-26 | — | — | US | disclosed |
| US-4602084-A | Monoazo dyes containing a 4-substituted-2-azo-1,1'-diphenylsulfone component | CIBA-GEIGY CORPORATION (US) | 1986-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120032121-A1 | METALLIC COMPOSITE AND COMPOSITION THEREOF | CDH1, EPCAM, CD4 | ALDH1A1 932/4885TDP1 4138/4885TP53 3320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.